Terminally sterilized medical devices must remain sterile and undamaged throughout transport and storage, making package design and testing critical. According to ISO 11607-2:2019, packaging must ensure devices can be sterilized and remain sterile until the sterile barrier is damaged or opened.
Controlled and qualified package designs and processes are essential to meet regulatory requirements and prevent risks such as patient harm, recalls, and loss of trust. Validating a sterile barrier system (SBS) involves design validation, process validation, and performance testing.